Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol and 5-fluorouracil for actinic keratosis
NCT02019355Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2013
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AKP01 in actinic keratosis (AK) (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: percentage of change in the number of actinic keratoses from baseline at 8 weeks. Started Oct 2013; status: completed.
02
Drugs
AKP01
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02019355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019355.